SOD2 and diabetic kidney disease: We confirmed and reported that apigenin, a flavonoid, was administered to diabetic model rats to activate Sirt3 by inhibiting NAD+-degrading enzyme CD38, and that mitochondrial oxidative stress and renal tubular cells injury of DKD were reduced by deacetylation of SOD2 and IDH2 [236].